Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,648 JPY | +5.41% | +0.53% | +6.09% |
2022 | Sunwels Co.,Ltd.(TSE:9229) added to S&P Global BMI Index | CI |
2022 | Certain Shares of Sunwels Co.,Ltd. are subject to a Lock-Up Agreement Ending on 24-SEP-2022. | CI |
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The firm trades with high earnings multiples: 29.68 times its 2025 earnings per share.
- The company appears highly valued given the size of its balance sheet.
- The company is not the most generous with respect to shareholders' compensation.
Ratings chart - Surperformance
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+6.09% | 471M | - | ||
+20.64% | 85.53B | C+ | ||
-28.19% | 71.18B | B- | ||
+0.99% | 26.76B | C+ | ||
+2.60% | 17.43B | A- | ||
-10.31% | 17.18B | B | ||
+2.19% | 15.65B | A- | ||
+78.22% | 13.71B | C- | ||
-24.91% | 13.1B | - | - | |
+79.75% | 13.27B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 9229 Stock
- Ratings Sunwels Co.,Ltd.